Ray Hershberger (born September 1953) is a board-certified American cardiologist in Columbus, Ohio. He subspecializes in adult congenital heart disease and heart failure and transplantation.
He is the Director, Division of Human Genetics in the Department of Internal Medicine, The Ohio State University.
Ray Hershberger Facts
- Full Name: Ray Elwin Hershberger
- Age: 69 years old
- Date of Birth: September 1953
- Occupation: Cardiologist
- Nationality: American
Ray Hershberger Medical School & Residency
- University of Utah Health – Fellowship, Cardiovascular Disease, 1985-1989
- University of Kansas School of Medicine (Wichita) – Residency, Internal Medicine, 1983-1984
- University of Kansas School of Medicine (Wichita) – Residency, Internal Medicine, 1979-1981
- MedStar Health – Internship, Internal Medicine, 1978-1979
- University of Nebraska College of Medicine – Medical School
Ray Hershberger Career
Hershberger established the Dilated Cardiomyopathy Research Project and serves as its chief investigator. He and his team continue their research to uncover and comprehend the genetics and genomes of human dilated cardiomyopathy and to apply new understanding to the practice of cardiovascular medicine.
Certifications & Licensure
- American Board of Internal Medicine – Certified in Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine – Certified in Cardiovascular Disease
- American Board of Internal Medicine – Certified in Internal Medicine
- NE State Medical License – Active through 2022
- UT State Medical License – Active through 1990
- OR State Medical License – Active through
- HI State Medical License – Active through 2008
- FL State Medical License – Active through 2013
- OH State Medical License – Active through 2024
- Ohio State University Wexner Medical Center, Columbus, OH
- James Cancer Hospital and Solove Research Institute, Columbus, OH
Dr. Ray Elwin Hershberger has the following 15 areas of expertise
- Pancreatic Cancer
- Unstable Angina
- Heart Attack
- Heart Diseases
- High Cholesterol
- Heart Block
- Heart Failure
- Dilated Cardiomyopathy
- Heart Transplantation
- Acute Coronary Syndrome (ACS)
- Blood Clot
- Aetna Choice POS II
- Aetna Health Network Option Open Access
- Aetna HMO
- Aetna Managed Choice POS Open Access
- Aetna Signature Administrators PPO
- Anthem Blue Access PPO
- Anthem Blue Preferred HMO
- CareSource Just4Me OH
- CIGNA HMO
- CIGNA Open Access Plus
- CIGNA PPO
- Coventry HealthAmerica PPO
- First Health PPO
- HealthSpan Access PPO
- Medmutual OhioHealth Network MRF
- MMOH SuperMed POS Select
- MMOH SuperMed PPO Plus
- Molina Mrktplace OH MRF
- Multiplan PPO
- PHCS PPO
- UHC Choice Plus POS
- UHC Navigate HMO
- UHC Navigate POS
- UHC Options PPO
Location & Contact Information
OSU Ross Heart Hospital
452 W 10th Ave Ste 1024E
Columbus, OH 43210
Fax: (614) 429-3286
Biomedical Research Tower
460 W 12th Ave Bldg 112
Columbus, OH 43210
Data provided by the National Library of Medicine
- Analysis of trends in hospitalizations for heart failure.
- Factors influencing knowledge of and adherence to self-care among patients with heart failure.
- Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes.
- Clinical profiles of four large pedigrees with familial dilated cardiomyopathy: preliminary recommendations for clinical practice.
- Familial dilated cardiomyopathy: echocardiographic diagnostic criteria for classification of family members as affected.
- Was the decreasing trend in hospital mortality from heart failure attributable to improved hospital care? The Oregon experience, 1991-1995.
- Comparative responsiveness of Short-Form 12 and Minnesota Living With Heart Failure Questionnaire in patients with heart failure.
- Distribution and declines in cardiac allograft radionuclide left ventricular ejection fractions in relation to late mortality.
- Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease.
- Nuggets, pearls, and vignettes of master heart failure clinicians. Part 1–the medical history.
- Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy.
- Periodic rescreening is indicated for family members at risk of developing familial dilated cardiomyopathy.
- Pre-operative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation.
- A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation.
- Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity.
- DCM Precision Medicine Study
- A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
Ray Hershberger Net Worth
Ray Hershberger has an estimated net worth of $8 million.
Ray Hershberger Twitter